A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical efficacy and safety in patients with mild or moderate
community-acquired pneumonia receiving a dose of 2 g of azithromycin in the SR formulation.